19-2816
3rd Cir.Feb 11, 2021Background
- Dr. Elias Karkalas, a family physician, reviewed and approved online prescriptions for Rx Limited (an internet pharmacy run by Paul Le Roux) from 2005–2012, including prescriptions for Fioricet.
- Fioricet contains butalbital, a barbiturate derivative that the Controlled Substances Act treats as Schedule III, though the Physicians’ Desk Reference did not list Fioricet as controlled during the relevant years.
- DEA investigators and a federal prosecutor concluded Fioricet was a controlled substance and charged Karkalas in an 85‑count Minnesota indictment; 38 counts named him, many relating to Fioricet distribution.
- Karkalas was detained pretrial, challenged the charges (unsuccessfully in the Minnesota court), and during trial the government dismissed all remaining Fioricet distribution counts; the jury later acquitted him of the other charges.
- Karkalas then brought (1) Bivens claims against the prosecutor and DEA investigator for Fourth and Fifth Amendment violations (malicious prosecution; fabricated evidence) and (2) an FTCA malicious‑prosecution claim against the United States.
- The district court dismissed the amended complaint with prejudice; on appeal the Third Circuit affirmed, holding the individual defendants entitled to qualified immunity because the complaint failed to plausibly allege constitutional violations, and that the FTCA claim was barred by the discretionary‑function exception.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Fourth Amendment malicious prosecution (pretrial detention) | Karkalas: prosecutor/investigator presented false/misleading testimony and prosecuted without probable cause, causing unlawful detention | Defendants: indictment creates a presumption of probable cause; plaintiff’s allegations about grand jury statements are speculative; qualified immunity applies | Dismissed — complaint fails to plausibly allege lack of probable cause or malice; individual defendants entitled to qualified immunity |
| Fifth Amendment fabricated‑evidence claim | Karkalas: government produced/used fabricated evidence/testimony that caused prosecution | Defendants: alleged grand jury statements are speculative; prosecutor’s pretrial advocacy statements were not evidence and no plausible allegation she knew they were false | Dismissed — complaint fails to plausibly allege fabricated evidence; qualified immunity applies |
| Availability of Bivens / prosecutorial immunity | Karkalas sought Bivens remedy for constitutional violations | Defendants invoked absolute/qualified immunities and argued Bivens is disfavored in this context | Court did not reach Bivens availability or absolute immunity because qualified immunity resolved the claims in defendants’ favor |
| FTCA malicious prosecution (state tort claim vs. U.S.) | Karkalas: United States liable under FTCA for malicious prosecution | U.S.: FTCA exceptions bar claim — discretionary‑function exception (and intentional tort exception for some acts) | Dismissed — discretionary‑function exception applies to investigative/prosecutorial decisions; sovereign immunity bars the FTCA claim |
Key Cases Cited
- Bivens v. Six Unknown Named Agents of Federal Bureau of Narcotics, 403 U.S. 388 (judicially implied damages remedy for constitutional violations by federal agents)
- Ziglar v. Abbasi, 137 S. Ct. 1843 (2017) (limits on extending Bivens remedies)
- Harlow v. Fitzgerald, 457 U.S. 800 (1982) (qualified immunity standard)
- Manuel v. City of Joliet, 137 S. Ct. 911 (2017) (Fourth Amendment governs pretrial detention claims)
- Gaubert v. United States, 499 U.S. 315 (1991) (FTCA discretionary‑function exception framework)
- Kaley v. United States, 571 U.S. 320 (2014) (indictment presumption of probable cause)
- Halsey v. Pfeiffer, 750 F.3d 273 (3d Cir. 2014) (fabricated‑evidence due process claim elements)
- Goodwin v. Conway, 836 F.3d 321 (3d Cir. 2016) (indictment rebuts malicious‑prosecution element analysis)
- Ashcroft v. Iqbal, 556 U.S. 662 (2009) (plausibility pleading standard)
- Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (2007) (plausibility standard for complaints)